Who
Susan Blum
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, CorMedix; Director, BiomX.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 11 Jul 2024
- Last trade
- 29 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Aug 2026filed 1 Sep 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $70K8,424 at $8.30 | filing |
| 29 Aug 2026filed 1 Sep 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $70K8,424 at $8.30 | filing |
| 23 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —72,820 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $71K9,767 at $7.27 | filing |
| 23 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —72,820 at $0.00 | filing |
| 23 Jan 2026filed 27 Jan 2026 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code F | $71K9,767 at $7.27 | filing |
| 29 Aug 2025filed 3 Sep 2025 | CRMD CorMedixPharmaceuticals | SEC FORM 4 Code A | —69,686 at $0.00 | filing |
| 14 Apr 2025filed 21 Apr 2025 | BiomXoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,600 at $0.00 | filing |
| 14 Apr 2025filed 18 Apr 2025 | BiomXoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,600 at $0.00 | filing |
| 11 Jul 2024filed 15 Jul 2024 | BiomXoption or derivative · Biotechnology | SEC FORM 4 Code A | —264,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.